Endoscopic Ultrasound Radiofrequency Ablation, Database Repository
EUS-RFA
1 other identifier
observational
100
1 country
1
Brief Summary
The purpose of having this database is to collect data related to endoscopic ultrasound RFA procedures performed by Indiana University EUS physicians for the treatment of tumors or adenopathy. This database is a repository database only, all information will be obtained in the electronic medical record. No additional clinical procedures will be performed outside current standard of care for endoscopic ultrasound. The patient will have already signed an informed consent for the endoscopic ultrasound. Subjects will be entered into the database for up to 10 years after the most recent procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2020
CompletedFirst Submitted
Initial submission to the registry
July 16, 2020
CompletedFirst Posted
Study publicly available on registry
January 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2030
February 18, 2026
February 1, 2026
10.5 years
July 16, 2020
February 16, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Incidence of any procedural complications that occur during the procedure on date of procedure.
This data will be used for to determine the clinical impact and safety of these procedures.
Day of procedure
Rate of patient report of symptoms related to procedure (Acute pancreatitis, abdominal pain, infection/abscess, venous thrombosis, & fever)
1 week phone follow up
1 week following procedure
Rate of patient report of symptoms related to procedure (Acute pancreatitis, abdominal pain, infection/abscess, venous thrombosis, & fever)
2 week phone follow up
2 weeks following procedure
Eligibility Criteria
Above 14 years of age and referred for treatment of benign or malignant tumor or adenopathy
You may qualify if:
- Subjects 14 years of age and older Referral for the treatment of a benign or malignant tumor or adenopathy
You may not qualify if:
- Subjects less than 14 years of age Unable to comprehend the study consent due to language or disability
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Indiana University Health University Hospital
Indianapolis, Indiana, 46202-5121, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Invstigator
Study Record Dates
First Submitted
July 16, 2020
First Posted
January 5, 2021
Study Start
July 1, 2020
Primary Completion (Estimated)
December 31, 2030
Study Completion (Estimated)
December 31, 2030
Last Updated
February 18, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share